Although some studies have shown ZEB2 can regulate tumor EMT, and a high ZEB2/E-cadherin ratio predicted poor overall survival 33,34; there are also some studies have shown expression of ZEB2 has nothing to do with EMT nor clinicopathological outcomes 35. Here, ZEB2 is linked to neoplasm.